medRxiv preprint doi: https://doi.org/10.1101/2020.10.30.20217364; this version posted November 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . 1 2 Therapeutic efficacy of Honey and Nigella sativa against COVID-19: 3 A multi-center randomized controlled clinical trial 4 (HNS-COVID-PK) 5 6 Sohaib Ashraf*#1, Shoaib Ashraf*#2, Moneeb Ashraf #3, Muhammad Ahmad Imran #4,5, 7 Larab Kalsoomȸ5, 6, Uzma Nasim Siddiquiȸ7, Muhammad Ghufranȸ8, Nighat Majeed6, 8 Iqra Farooq9,10, Zaighum Habib11, Abubakar Hilal1, Zain-ul-Abdin1,12, Ayesha Khaqan1, 9 Muhammad Kiwan Akram13, Sidra Ashraf14, Rutaba Akmal15, Sundas Rafique5,16, 10 Khawar Nawaz17, Shahroze Arshad12,18, Suhail Ahmad19, Kanwal Hayat1, Ali Arshad5, 11, 20, 11 Muhammad Faisal Nadeem21, Muhammad Hassan22, Abeer-bin-Awais23, Muhammad Azam24, 12 Muhammad Suhail26, Sibgha Zulfiqar27, Imran Anwar28, Saulat Sarfraz23, Ayesha Hamayoun29, 13 Amber Malik30. Hui Zheng31,32, Talha Mahmood33, Mahmood Ayyaz10,34, Ali Ahmad*35, 14 Muhammad Ashraf *36, Qazi Abdul Saboor *1, Mateen Izhar *4 15 16 Corresponding email address:
[email protected] 17 * Corresponding authors 18 # Joint First Author 19 ȸ Joint Second Author 20 21 Affiliations: 22 1. Department of Cardiology, Shaikh Zayed Post-Graduate Medical Institute, Lahore, 23 Pakistan. 24 2. Department of Pathobiology, Riphah College of Veterinary Sciences, Riphah University, 25 Lahore, Pakistan. 26 3. Department of Pharmacology, Kingedward Medical University, Mayo Hospital, Lahore, 27 Pakistan.